Literature DB >> 32895556

Mechanisms for target recognition and cleavage by the Cas12i RNA-guided endonuclease.

Heng Zhang1, Zhuang Li2, Renjian Xiao2, Leifu Chang3,4.   

Abstract

Cas12i is a recently identified type V CRISPR-Cas endonuclease that predominantly cleaves the non-target strand of a double-stranded DNA substrate. This nicking activity of Cas12i could potentially be used for genome editing with high specificity. To elucidate its mechanisms for target recognition and cleavage, we determined cryo-EM structures of Cas12i in multiple functional states. Cas12i pre-orders a seven-nucleotide seed sequence of the crRNA for target recognition and undergoes a two-step activation through crRNA-DNA hybridization. Formation of 14 base pairs activates the nickase activity, and 28-bp hybridization promotes cleavage of the target strand. The atomic structures and mechanistic insights gained should facilitate the manipulation of Cas12i for genome editing applications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32895556      PMCID: PMC8256696          DOI: 10.1038/s41594-020-0499-0

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  52 in total

Review 1.  CRISPR-Cas immunity in prokaryotes.

Authors:  Luciano A Marraffini
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

Review 2.  Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.

Authors:  Addison V Wright; James K Nuñez; Jennifer A Doudna
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

Review 3.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

Review 4.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.

Authors:  Rodolphe Barrangou; Luciano A Marraffini
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 5.  CRISPR-Cas9 Structures and Mechanisms.

Authors:  Fuguo Jiang; Jennifer A Doudna
Journal:  Annu Rev Biophys       Date:  2017-03-30       Impact factor: 12.981

Review 6.  CRISPR-mediated adaptive immune systems in bacteria and archaea.

Authors:  Rotem Sorek; C Martin Lawrence; Blake Wiedenheft
Journal:  Annu Rev Biochem       Date:  2013-03-11       Impact factor: 23.643

Review 7.  Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.

Authors:  Prarthana Mohanraju; Kira S Makarova; Bernd Zetsche; Feng Zhang; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

Review 8.  The Biology of CRISPR-Cas: Backward and Forward.

Authors:  Frank Hille; Hagen Richter; Shi Pey Wong; Majda Bratovič; Sarah Ressel; Emmanuelle Charpentier
Journal:  Cell       Date:  2018-03-08       Impact factor: 41.582

9.  Diversity and evolution of class 2 CRISPR-Cas systems.

Authors:  Sergey Shmakov; Aaron Smargon; David Scott; David Cox; Neena Pyzocha; Winston Yan; Omar O Abudayyeh; Jonathan S Gootenberg; Kira S Makarova; Yuri I Wolf; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2017-01-23       Impact factor: 60.633

Review 10.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

View more
  9 in total

1.  Structural basis of target DNA recognition by CRISPR-Cas12k for RNA-guided DNA transposition.

Authors:  Renjian Xiao; Shukun Wang; Ruijie Han; Zhuang Li; Clinton Gabel; Indranil Arun Mukherjee; Leifu Chang
Journal:  Mol Cell       Date:  2021-08-26       Impact factor: 17.970

2.  Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing.

Authors:  Yangcan Chen; Yanping Hu; Xinge Wang; Shengqiu Luo; Ning Yang; Yi Chen; Zhikun Li; Qi Zhou; Wei Li
Journal:  Innovation (Camb)       Date:  2022-05-26

3.  DNA interference states of the hypercompact CRISPR-CasΦ effector.

Authors:  Patrick Pausch; Katarzyna M Soczek; Dominik A Herbst; Connor A Tsuchida; Basem Al-Shayeb; Jillian F Banfield; Eva Nogales; Jennifer A Doudna
Journal:  Nat Struct Mol Biol       Date:  2021-08-11       Impact factor: 15.369

4.  Cryo-EM structure of the RNA-guided ribonuclease Cas12g.

Authors:  Zhuang Li; Heng Zhang; Renjian Xiao; Ruijie Han; Leifu Chang
Journal:  Nat Chem Biol       Date:  2021-01-25       Impact factor: 15.040

5.  Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1.

Authors:  Bo Zhang; Diyin Luo; Yu Li; Vanja Perčulija; Jing Chen; Jinying Lin; Yangmiao Ye; Songying Ouyang
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

Review 6.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

7.  Structure of a type IV CRISPR-Cas ribonucleoprotein complex.

Authors:  Yi Zhou; Jack P K Bravo; Hannah N Taylor; Jurre A Steens; Ryan N Jackson; Raymond H J Staals; David W Taylor
Journal:  iScience       Date:  2021-02-17

8.  Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR-Cas12f nuclease.

Authors:  Renjian Xiao; Zhuang Li; Shukun Wang; Ruijie Han; Leifu Chang
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

Review 9.  Structural principles of CRISPR-Cas enzymes used in nucleic acid detection.

Authors:  Anuska Das; Hemant N Goswami; Charlisa T Whyms; Sagar Sridhara; Hong Li
Journal:  J Struct Biol       Date:  2022-02-02       Impact factor: 2.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.